PERSPECTIVE
The genetics of complex ophthalmic disorders K Evans, AC Bird 'Complex inheritance' is a relatively new term for multifactorial, polygenic, or quantitative inheritance that identifies characteristics, traits, or diseases that are determined by a number of genes. In some cases there may also be an environmental component to aetiology. Examples of such disorders are Alzheimer's disease, schizophrenia, bipolar affective disorder, hypertension, heart disease, and arthritis. In the 19th century this phenomenon was recognised as 'blending of inheritance' with progeny exhibiting phenotypes intermediate between parents. One of the great achievements of mendelian genetic (particulate) theory leading to its general acceptance was to explain this effect as the transmission of many different mendelian factors. ' In developed countries the three most prevalent causes of blindness-age-related macular degeneration (ARMD), diabetic retinopathy, and glaucoma2 are all thought to be aetiologically complex. Progress in molecular genetics now gives us sufficient understanding of the structure of the genome and the refined techniques to be able to begin to unravel their complexity with the promise of developing novel approaches to the management of patients with these conditions.
In this article an overview of the published work on aetiological influences in each of these diseases is presented with an outline of the molecular genetic methods that are most likely to lead to the identification of the responsible genetic abnormalities.
Age-related macular degeneration In Great Britain, 50% of the 35 000 blind and partially sighted registrations per year are attributable to ARMD and recent reports suggest that the incidence of the disease is rising.3 The term ARMD applies to patients over 50 years of age and describes morphological changes at the macula which include soft drusen, abnormal pigmentation, geographic atrophy, and subretinal neovascularisation with subretinal scarring.4 Importantly, these features can be signs of other retinal dystrophies (for example, Sorsby's fundus dystrophy, Doyne's honeycomb dystrophy, malattia levantinese) which can usually be differentiated from ARMD on the basis of establishing the appearance of these signs in other members of the patient's family before the sixth decade of life.5 It should be stressed that this definition does not assume that ARMD is a single aetiological entity.
GENETIC INFLUENCES
Many studies have suggested a role for genetics in the aetiology of ARMD and it seems likely that genetic predisposition is the strongest risk factor apart from advanced age. Hyman et al 6in a case-control study identified a significant increase in the incidence of ARMD in the siblings of affected individuals. This family association has been confirmed in twin studies'-9 and Silvestri et al'0 have suggested a 19 times relative risk of the condition in family members of affected individuals. Piguet et al'1 compared sibling pairs with spouses and demonstrated concordance of macular drusen between siblings but not with spouses sharing a common environment. This suggested that genetic background was the most important aetiological factor.
Further evidence suggesting a role for genetic influences has been the possible associations between sex'2 and race" and ARMD. This latter association may involve the protective effect of ocular pigmentation as reflected in iris colour'4 or changes in iris colour with age.'5 Heiba et al '6 undertook sibling correlation studies to quantify the role of genetic influences in ARMD in 564 families. A major genetic influence was confirmed in the aetiology of ARMD. Moreover, it was concluded, a single major gene could account for most of the variability of disease in this community. No specific gene or genomic locus has yet been positively associated with ARMD. The various genetic loci linked to monogenetic disorders that affect the macula," 1 in particular those loci that include the retinal genes peripherinlRDS'9 and TIMP32" would be appropriate starting points for a genome search for ARMD susceptibility genes.
ENVIRONMENTAL INFLUENCES
Weaker and inconsistent risks have been found with a wide range of other exposures. For example, cardiovascular disease,2' 22 alcohol consumption (specifically beer),2' reproductive history, and exposure to exogenous oestrogens in women,24 smoking (most significantly associated with submacular neovascularisation),25 and plasticisers contaminating ingested food26 have all been associated with ARMD.
This has led to the hypothesis that modification of environmental influences may lead to reduction of ARMD severity.
A major area of interest has been the influence of oxidative metabolism within the retina, light exposure, and the supplementation of diet with antioxidants.2' Normal metabolism with ultraviolet and high energy visible light exposure can trigger the formation of highly reactive free radicals leading to degradation of cellular proteins and polyunsaturated fatty acids. Cellular mechanisms designed to combat this may be particularly deficient in ARMD patients leading to accumulation of peroxidation products. Although histological changes similar to ARMD have been seen in animals exposed to light, no similar changes have been seen in human studies. Correlation of ARMD with antioxidant dietary content in humans has suggested possible protective roles for vitamins A, C, and E and selenium. 28 29 Despite these positive associations between ARMD and environment, an almost equal number of studies find no associations.4
Diabetic retinopathy Chronic hyperglycaemia is considered by far the major determinant of diabetic retinopathy. Previous controversy regarding the benefit of 'tight' control of hyperglycaemia has now been resolved with long term, strict control regimes resulting in significantly less progression of retinopathy.'0" Other factors determining whether a patient with diabetes mellitus will develop retinopathy and its rate of progression probably exist. Prolonged hyperglycaemia secondary to other conditions-for example, pancreatitis, haemochromatosis, and acromegaly, are infrequently associated with retinopathy.'2 The retinopathy seen in diabetes mellitus caused by mitochondrial mutations is atrophic rather than a vasculopathy." " Proliferative disease is more prevalent for any given duration of time in insulin dependent compared with non-insulin dependent cases. '5 36 In addition, proliferative retinopathy is seen significantly more often in diabetics with HLA-DR phenotypes 4/0, 3/0, and X/X when compared with control diabetic patients matched for age, sex, and duration of diabetes.'7 The role of other components in the aetiology of diabetic retinopathy may be small. This is in contrast with diabetic nephropathy in which a significant, second component (genetic) in addition to hyperglycaemia has been proposed based on the observation that the incidence of nephropathy in insulin dependent diabetes, rather than steadily increasing with the duration of hyperglycaemia, declines rapidly after a period of 15 years. '8 The underlying genetic abnormalities predisposing to systemic diabetes mellitus are therefore the most important factors in diabetic retinopathy aetiology. Whether one or more of the specific genetic abnormalities associated with systemic diabetes mellitus will be associated with an enhanced risk of retinopathy remains to be determined.
GENETIC INFLUENCES
Most work that has been undertaken on the aetiology of diabetes has related to type 1 or insulin dependent diabetes (IDDM). The importance of a genetic component has been established in many studies. The risk of IDDM in siblings of affected patients is on average 6% compared with a population frequency of only 0.4% in whites of European descent.'9 Non-parametric linkage analysis in humans has identified at least 12 genetic loci contributing to the aetiology of IDDM.4' By far the most important (IDDM1) has been localised to the HIA region of chromosome 6p21 and relates to polymorphisms within the peptide binding sites of the class II molecules HLA-DQ and HLA-DR. IDDMI accounts for 35% of the clustering observed in families. The next most significant association is with IDDM2 which localises to a variable number tandem repeat sequence in the insulin gene (INS) on chromosome 1p5.40 Variation within the class I ( -40 repeats) and class III (-150 repeats) alleles at this locus is thought to influence INS transcription,4' but a direct causal link between this effect and diabetes susceptibility has yet to be established. Other quantitatively less important loci are localised to chromosomes 15q, 1ql3, 6q25, 18q, 2q31, 6q27, 3q21-q25, 10cen (IDDM3-10), the X chromosome (at locus DXS1068), and the glucokinase gene (GCK) on chromosome 7p. 4 Family and twin studies have also confirmed a strong genetic component to type 2 non-insulin dependent diabetes (NIDDM)4' although contrary to previous work this is not as great as is seen in IDDM. 4 
Molecular genetic methodology
Recombinant DNA technology and knowledge of the organisation of the human genome have become sufficiently refined over the past decade to make the task of identifying the genetic abnormalities leading to complex traits a practical possibility. Of particular importance has been the development of genetic markers (mapping to known genomic loci), based on the wealth of DNA polymorphisms that have been identified in the genome. These allow for the localisation of genetic abnormalities of interest to genomic regions sufficiently small to be screened using physical mapping technology.7' The task of identifying predisposing genetic abnormalities in complex traits proceeds along the following sequence of events: non-parametric linkage analysis to identify important genomic regions, locus refinement-for example, using linkage disequilibrium mapping, the construction of a physical contig of the regions of interest, and the screening of candidate genes for disease related mutations.
LINKAGE ANALYSIS
Conventional linkage analysis requires the study of extended, affected pedigrees in which the disease status of each individual and the mode of inheritance are known, with the assumption of a single disease locus. Such pedigrees are rarely, if ever, available for complex traits and mode of inheritance-the relative contributions of dominant, recessive, X linked, and/or mutifactorial inheritance, leading to the disease in the population of interest is often unknown. These assumptions do not apply to 'model free' non-parametric linkage analysis. Two statistical methods have been developed-affected sib pair and affected pedigree member analysis."4 The former method will be described here since it has been the most successful; affected pedigree member methodology is the least statistically powerful and still requires the construction of (albeit small) pedigrees.
Affected sib pair analysis"" conventionally involves the study of two affected relatives (siblings) in a pedigree to determine whether they have inherited identical copies of a chromosomal region from a common ancestor. This to some extent will happen by chance, but if seen in a large number of affected sibships the association between the chromosomal location and the disease becomes more significant. It has recently been suggested that the most efficient sib pair studies are those where sibs are either concordant (both exhibiting near identical features of the disease) or extremely disconcordant (one affected, the other normal).'8 Since the identification of such disconcordant pairs, especially in ARMD and POAG, can be prone to diagnostic error (for example, a normal examination may not guarantee an unaffected status), concordant sib pairs are usually the better study design.
An important determination before undertaking such a study is to decide on the size of the sib pair group to be investigated. This is dependent firstly upon the total contribution that susceptibility loci make to the risk of developing the disease. This is called the risk ratio, s, which may be calculated as the risk to a sibling of an affected proband versus the prevalence in the general population. For ARMD this is 10-30 1 7' and for IDDM is 15.40 The second important factor is the threshold to be accepted as a sign of significant linkage. This is determined by the maximum lod score statistic, T. For a monogenic disease T=3 corresponds to odds of 1:1000 in favour of linkage. During an initial total genome search (using marker loci 15 cM apart) susceptibility loci with <2 might be missed if the threshold used as suggestive of linkage were as high as this. Therefore at this stage T= 1.5 may be more appropriate. This was the situation with diabetes where many of the lesser susceptibility loci would have been missed if a high threshold had been used initially.80 In the case of ARMD however it has been suggested that a single genomic locus is associated with most of the genetic risk.'6 A high threshold would still detect this locus. Many authors have proposed, and recent comparisons of concordance rates in monozygotic twins-100% versus dizygotic twins-28% to 42%9 suggest, that underlying susceptibility to ARMD may involve a number of genes.8' The best interpretation of these studies therefore would be that a number of susceptibility loci are involved but that one locus is associated with most risk. Therefore, during a first stage genome search in ARMD, a maximum lod score statistic of T= 1.5 would be prudent to ensure that these minor susceptibility loci are not missed. Using this information, power graphs based on Risch et al,76 100 sib pairs and polymorphic microsatellite markers at 15 cM intervals, the probability of detecting minor susceptibility loci with 1.5 would be >90%.
The power statistic described above is based on haplotype data identical by descent (IBD). The power of affected sib pair studies in ARMD and POAG would be reduced to some extent since parental haplotypes would rarely be available and statistical analysis would be based on identical by state (IBS) data. In practice, this loss of power may be small especially if highly polymorphic microsatellite markers with polymorphism information contents (PIC) 0.8 were used. 82 Loci highlighted during a first stage genome scan are then studied intensively using microsatellite markers mapping more densely in the regions of interest. When each locus is looked at closely true susceptibility loci will then give higher lod scores. In an affected sib pair analysis, significant linkage is obtained when T=3.6 and highly significant linkage when T=5.4.8" It has also been suggested that to confirm the significance of identified susceptibility loci a second complete genome scan or a 'replication study'84 on an independent group of sib pairs be undertaken.84 Failure to replicate a linkage result, however, may be due to population heterogeneity rather than suggesting error in the original study.
Simple affected sib pair analysis assumes that each locus identified contributes independently to disease susceptibility (genetic heterogeneity). As has been seen in diabetes, this may not be the case. Epistatic interaction occurs when the genotype at one locus has an effect on the contribution made by another locus. Such interactions suggest that the susceptibility genes at the two loci encode proteins that act on the same or related biochemical pathways. Detailed genetic information on ARMD, diabetic retinopathy, and glaucoma will emerge over the next few years. It is to be expected that this will lead to dramatic changes in the way these important ophthalmic diseases are perceived, undoubtedly resulting in improved clinical management.
